Forward Management LLC cut its position in shares of CME Group Inc (NASDAQ:CME) by 5.3% during the first quarter, according to its most recent filing with the SEC. The fund owned 10,404 shares of the financial services provider’s stock after selling 588 shares during the period. Forward Management LLC’s holdings in CME Group were worth $1,235,000 at the end of the most recent quarter.
Other large investors have also bought and sold shares of the company. Hudock Capital Group LLC boosted its position in CME Group by 0.5% in the third quarter. Hudock Capital Group LLC now owns 3,726 shares of the financial services provider’s stock valued at $389,000 after buying an additional 20 shares during the last quarter. TNB Financial boosted its position in CME Group by 1.8% in the third quarter. TNB Financial now owns 10,035 shares of the financial services provider’s stock valued at $1,049,000 after buying an additional 175 shares during the last quarter. Commerce Bank boosted its position in CME Group by 66.7% in the third quarter. Commerce Bank now owns 474,163 shares of the financial services provider’s stock valued at $49,559,000 after buying an additional 189,773 shares during the last quarter. Nippon Life Global Investors Americas Inc. boosted its position in CME Group by 2.6% in the third quarter. Nippon Life Global Investors Americas Inc. now owns 93,890 shares of the financial services provider’s stock valued at $9,812,000 after buying an additional 2,420 shares during the last quarter. Finally, Lockheed Martin Investment Management Co. purchased a new position in CME Group during the third quarter valued at $1,254,000. Institutional investors and hedge funds own 80.06% of the company’s stock.
Shares of CME Group Inc (NASDAQ:CME) traded up 0.77% during trading on Friday, hitting $116.65. The stock had a trading volume of 824,991 shares. The company has a market capitalization of $39.64 billion, a PE ratio of 25.25 and a beta of 0.88. The firm has a 50-day moving average price of $117.48 and a 200 day moving average price of $117.90. CME Group Inc has a 52 week low of $92.29 and a 52 week high of $127.60.
CME Group (NASDAQ:CME) last issued its earnings results on Thursday, April 27th. The financial services provider reported $1.22 earnings per share for the quarter, beating the consensus estimate of $1.20 by $0.02. The company had revenue of $929 million during the quarter, compared to analysts’ expectations of $932.06 million. CME Group had a return on equity of 7.28% and a net margin of 42.67%. CME Group’s quarterly revenue was down .5% compared to the same quarter last year. During the same period in the prior year, the business posted $1.15 EPS. Equities analysts anticipate that CME Group Inc will post $4.88 earnings per share for the current year.
WARNING: This report was first published by Markets Daily and is the sole property of of Markets Daily. If you are viewing this report on another domain, it was stolen and reposted in violation of US & international trademark and copyright law. The original version of this report can be accessed at https://www.themarketsdaily.com/2017/05/19/cme-group-inc-cme-shares-sold-by-forward-management-llc.html.
CME has been the topic of several recent research reports. JPMorgan Chase & Co. cut CME Group from an “overweight” rating to a “neutral” rating in a research report on Tuesday, January 31st. Zacks Investment Research raised CME Group from a “sell” rating to a “hold” rating in a report on Monday, March 20th. Deutsche Bank AG reduced their target price on CME Group from $137.00 to $134.00 and set a “buy” rating on the stock in a report on Friday, April 28th. Royal Bank of Canada reduced their target price on CME Group from $133.00 to $130.00 and set an “outperform” rating on the stock in a report on Monday, May 1st. Finally, Jefferies Group LLC reissued a “buy” rating and set a $128.00 target price on shares of CME Group in a report on Saturday, March 11th. One investment analyst has rated the stock with a sell rating, six have given a hold rating and three have given a buy rating to the company’s stock. The company has an average rating of “Hold” and a consensus target price of $111.90.
In related news, CFO John W. Pietrowicz sold 2,500 shares of the stock in a transaction dated Monday, April 10th. The stock was sold at an average price of $117.85, for a total transaction of $294,625.00. Following the completion of the sale, the chief financial officer now directly owns 40,995 shares in the company, valued at approximately $4,831,260.75. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. Also, Director Ronald A. Pankau sold 500 shares of the stock in a transaction dated Friday, February 24th. The shares were sold at an average price of $122.11, for a total value of $61,055.00. Following the sale, the director now owns 3,500 shares of the company’s stock, valued at $427,385. The disclosure for this sale can be found here. Insiders have sold a total of 13,030 shares of company stock valued at $1,581,964 over the last 90 days. 0.61% of the stock is currently owned by company insiders.
CME Group Company Profile
CME Group Inc, through its exchanges, provides products across all asset classes, including futures and options based on interest rates, equity indexes, foreign exchange, energy, agricultural products and metals. The Company’s segment primarily consists of the Chicago Mercantile Exchange Inc (CME), Board of Trade of the City of Chicago, Inc (CBOT), New York Mercantile Exchange, Inc (NYMEX) and Commodity Exchange, Inc (COMEX) exchanges.
Receive News & Ratings for CME Group Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group Inc and related companies with MarketBeat.com's FREE daily email newsletter.